Classification
Product TypeProcessed Food
Product FormPackaged dietary supplement (e.g., tablets/capsules/drops)
Industry PositionFinished Consumer Health Product
Market
In Uzbekistan, iodine-related public health policy is anchored by a national law on preventing iodine-deficiency diseases, with the Ministry of Health responsible for setting requirements for iodine-containing preparations used in iodization programs. Dietary supplements (biologically active additives/BAAs), including iodine supplements marketed as BAAs, fall under sanitary-epidemiological oversight, including an official electronic catalog presence for BAAs. Authorities have also highlighted risks from counterfeit/unregistered BAAs and have tightened governance around permitting and supervision. Policy direction under the presidential decree PF-13 (28 Jan 2025) emphasizes accelerated pharmaceutical development, including the dietary supplement segment, which reinforces a compliance-driven market environment.
Market RoleDomestic consumer market with import dependence (trade volumes not verified in this record); compliance-driven BAA/medicine classification risk
Domestic RoleConsumer-facing supplement category sold through regulated retail channels, with heightened scrutiny on lawful registration and truthful product positioning (BAA vs medicine).
Market GrowthNot Mentioned
Risks
Regulatory Compliance HighThe most critical market-access risk is product classification and registration: a purported dietary supplement (BAA) can be determined to have a medicine-equivalent composition/positioning, triggering a requirement to register and circulate it as a medicine rather than as a BAA. Noncompliance can lead to withdrawal from sale, return of authorizations, seizure, and disruption of import and retail channels.Obtain a formal classification/registration pathway confirmation (BAA vs medicine) before shipment; ensure claims and labeling match the approved dossier; maintain complete authorization documentation for customs and retail inspection.
Counterfeit And Illegal Circulation HighAuthorities and traceability stakeholders have reported a significant share of BAAs circulating illegally or as counterfeit/unregistered goods, creating enforcement and reputational risks for legitimate importers and pharmacy retailers.Use authorized distributors; maintain batch/expiry traceability records; consider participation in national traceability/digital labeling initiatives where applicable; conduct authenticity checks and retain supplier verification files.
Regulatory Compliance MediumPermitting/authorization workflows for biologically active substances/supplements have incorporated mandatory intellectual property rights compliance checks via an Intellectual Property portal (reported effective from March 1, 2026), increasing the risk of delays or denial if brand/trademark/design rights are unclear.Pre-screen trademarks/industrial designs and ensure right-to-use documentation is ready before submitting for import/production permissions; align product naming and packaging with documented IP rights.
Food Safety MediumIodine preparations and iodine-related products are a regulated public-health area in Uzbekistan’s iodine-deficiency prevention framework; potency consistency, correct dosing directions, and truthful labeling are critical to avoid adverse health outcomes and regulatory action.Implement robust quality control for iodine content and stability; ensure label instructions and warnings are medically appropriate and consistent with the approved registration dossier; avoid therapeutic claims if registered as a BAA.
Logistics LowUzbekistan’s landlocked geography can introduce multimodal border and transit delays that affect replenishment cycles; delays are most disruptive when products are held pending documentation or classification checks.Build lead-time buffers; pre-clear documentation; use experienced customs brokers familiar with supplement/health-product classification and sanitary requirements.
Labor & Social- Consumer protection risk from misleading presentation (dietary supplement sold/positioned as a medicine) and incomplete/incorrect product information at retail
- High exposure to illegal circulation/counterfeit products in the BAA segment has been explicitly raised by Uzbek traceability/labeling stakeholders and authorities
FAQ
Which Uzbek authority provides an official reference point for biologically active additives (dietary supplements) in circulation?The Committee for Sanitary and Epidemiological Well-Being and Public Health of the Republic of Uzbekistan provides an official government-portal reference for an electronic catalog of biologically active additives.
Why does the BAA (dietary supplement) vs medicine distinction matter for iodine supplements in Uzbekistan?Because Uzbek authorities have documented cases where a product sold as a biologically active additive was found to have a medicine-equivalent composition, which can require the product to be registered and circulated as a medicine rather than as a dietary supplement.
What additional compliance check can affect permissions for importing or producing biologically active supplements in Uzbekistan in 2026?Sanitary-epidemiological authorities reported that, starting from March 1, 2026, compliance with intellectual property rights must be checked via an Intellectual Property portal during the permission process for importing and producing biologically active substances and dietary supplements.